COPE - COVID-19 in Pregnancy and Early Childhood
- Conditions
- Covid-19Pregnancy ComplicationsPregnancy PretermPregnancy in DiabeticNeonatal InfectionSars-CoV2
- Interventions
- Other: biological samples, questionnaires and interviews
- Registration Number
- NCT04433364
- Lead Sponsor
- Sahlgrenska University Hospital, Sweden
- Brief Summary
Purpose: The emergence of a new coronavirus SARS-CoV-2 causing a novel infection in the human race resulting in a world-spanning pandemic came as a surprise and at a tremendous cost both for individual human lives as well as for the society and the health care sector. The knowledge on how this new infection affects both the mother and the unborn child as well as the outcomes for the mother and the child in the long run are unknown. What is known is based on case-reports and small case-series solely. Both the coronaviruses causing Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS) can cause a threat to pregnant women and their offspring, which leads to the question whether this could be the case also for SARS-CoV-2.
Aims: To establish a biobank of biological material from infected as well as non-infected pregnant women and their offspring. To combine this biobank with Swedish quality and health care registers, computerized patient charts and questionnaire data, enabling both short-term follow up, such as obstetric outcomes, as well as long-term outcomes both for mother and child. To study how the pandemic situation affects both the mother and her partner in their experience of pregnancy, childbirth, and early parenthood.
Design: A national Swedish multicentre study. Women are included when they have a positive test for SARS-CoV-2 or a clinical suspicion of coronavirus disease 2019 (COVID-19) (COVID-19 group). Pregnant women without COVID-19 symptoms will be included at their routine visits (Screening group). Blood samples and other biological material will be collected at different time-points. Additional predictors and outcomes are collected from the Swedish Pregnancy Register as well as obligatory Swedish health registers. The biobank and its linkage to health registers through the Swedish personal identification number will enable future research. Child development will be followed during the first year of life by questionnaires to the parents. Womens' and their partners' experience of childbirth and parenthood will be studied in form of questionnaires as well as in form of interviews.
Conclusion: This project will help obstetricians and neonatologists better recognize clinical manifestations of the virus, identify possible risk factors during pregnancy and tailor therapies alongside providing right level of surveillance and management during pregnancy, delivery, and child health care.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- Female
- Target Recruitment
- 3834
- Pregnant women 18 years of age and above
- Attending routine antenatal visits at a participating hospital during the study period or are strongly suspicious of or diagnosed with Covid-19 during pregnancy.
- For the questionnaire part: language knowledge (Swedish, English, Arabic, Somali)
- For the interview part: Swedish language knowledge
• Another language but selected ones
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Screening group biological samples, questionnaires and interviews a general population of women giving birth, called "screening group" included at routine antenatal visits, their partners, and children COVID-19 group biological samples, questionnaires and interviews group of women testing positive for SARS-CoV-2 or falling ill with COVID-19, called "COVID-19 group", their partners, and children
- Primary Outcome Measures
Name Time Method Experiences of pregnancy during a pandemic 1 year study how women and their partners experience pregnancy, childbirth and early parenthood in the COVID-19-pandemic, both for women not tested and for women tested positive for SARS-CoV-2.
Biobank with linkage to registers 1-20 years establish a biobank and database with bio-samples from both women that are not tested and presumed healthy as well as possibly ill and women confirmed tested positive for SARS-CoV-2 and their infants linked to Swedish health care registers including socio-economic factors and use serological and viral analyses from the biological samples to evaluate maternal, fetal and neonatal outcomes.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (27)
Karolinska University Hospital- Huddinge
🇸🇪Stockholm, Sweden
Helsingborgs lasarett
🇸🇪Helsingborg, Skåne, Sweden
Eskiltuna hospital
🇸🇪Eskilstuna, Södermanland, Sweden
Sahlgrenska Univeristy Hospital
🇸🇪Gothenburg, VGR, Sweden
Kristiandstad länssjukhus
🇸🇪Kristianstad, Sweden
Linköping University Hospital
🇸🇪Linköping, Östergötland, Sweden
Vrinnevisjukhuset
🇸🇪Norrköping, Östergötland, Sweden
Skåne Universitetssjukhus
🇸🇪Lund, Skåne, Sweden
Boras hospital
🇸🇪Boras, VGR, Sweden
Skaraborgs sjukhus Skövde
🇸🇪Skövde, Sweden
Karlstad lasarett
🇸🇪Karlstad, Sweden
Halmstad lasarett
🇸🇪Halmstad, Halland, Sweden
Varbergs sjukhus
🇸🇪Varberg, Halland, Sweden
Södertälje
🇸🇪Stockholm, Sweden
Falu Hospital
🇸🇪Falun, Dalarna, Sweden
Kalmar Lasarett
🇸🇪Kalmar, Sweden
Karolinska University Hospital Solna
🇸🇪Stockholm, Sweden
Södersjukhuset
🇸🇪Stockholm, Sweden
Sundsvall
🇸🇪Sundsvall, Sweden
Umeå University Hospital
🇸🇪Umeå, Sweden
Uppsala University Hospital
🇸🇪Uppsala, Sweden
Västerås
🇸🇪Västerås, Sweden
Ryhovs sjukhus
🇸🇪Jönköping, Sweden
BB Stockholm
🇸🇪Stockholm, Sweden
Danderyd
🇸🇪Stockholm, Sweden
Örebro University Hospital
🇸🇪Örebro, Sweden
Ystad
🇸🇪Ystad, Sweden